Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review

Symptoms consistent with dysfunction of the frontal lobes can occur following traumatic brain injury (TBI) or other types of acquired brain injury (stroke, aneurysm). These symptoms can include problems with short-term memory, attention, planning, problem solving, impulsivity, disinhibition, poor mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of neuropsychiatry and clinical neurosciences 1997, Vol.9 (2), p.222-230
Hauptverfasser: Kraus, M F, Maki, P M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 230
container_issue 2
container_start_page 222
container_title The journal of neuropsychiatry and clinical neurosciences
container_volume 9
creator Kraus, M F
Maki, P M
description Symptoms consistent with dysfunction of the frontal lobes can occur following traumatic brain injury (TBI) or other types of acquired brain injury (stroke, aneurysm). These symptoms can include problems with short-term memory, attention, planning, problem solving, impulsivity, disinhibition, poor motivation, and other behavioral and cognitive deficits ("frontal lobe syndrome"). These symptoms may respond to certain drugs, such as dopaminergic agents. This case series describes results of using amantadine in 7 patients with this type of symptom profile (6 with TBI, 1 with meningitis following sinus surgery). Patients received neuropsychiatric examinations and serial neuropsychological testing. All patients showed some degree of positive response. One had side effects that resolved upon discontinuation of drug. The rationale for using dopaminergics is discussed, and pertinent literature is reviewed.
doi_str_mv 10.1176/jnp.9.2.222
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79008447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79008447</sourcerecordid><originalsourceid>FETCH-LOGICAL-a317t-56afffb769f4896137628fbe6b182b78b2123b5e5bcf0a0a20d7e45a63223c803</originalsourceid><addsrcrecordid>eNptkM1LwzAYxoMoc05PnoWcRJDOJP1I603G_ICBFz2HpH3DMtqkJq3S_96MDU-e3geeHw-8P4SuKVlSyouHne2X1ZItGWMnaE7zLE94zKdoTsoqTwjl7BxdhLAjhLC0yGZoVtEso4TOUVhrDfWAncayk3aQjbGAt1PjXb1tnTcNYGdxmLp-cF3Yc9q7yLW4dQpwMwU92nowETIWKy_NPuxGPz3iWgbAYRgbAwFL22AP3wZ-LtGZlm2Aq-NdoM_n9cfqNdm8v7ytnjaJTCkfkryQWmvFi0pnZVXQlBes1AoKRUumeKkYZanKIVe1JpJIRhoOWS6LlLG0Lkm6QLeH3d67rxHCIDoTamhbacGNQfCKkDLLeATvD2DtXQgetOi96aSfBCVir1hExaISTEStkb45zo6qg-aPPTqN_d2hl31vxM6N3sYv_536BQZkhis</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79008447</pqid></control><display><type>article</type><title>Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review</title><source>MEDLINE</source><source>American Psychiatric Publishing Journals (1997-Present)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Psychiatry Legacy Collection Online Journals 1844-1996</source><creator>Kraus, M F ; Maki, P M</creator><creatorcontrib>Kraus, M F ; Maki, P M</creatorcontrib><description>Symptoms consistent with dysfunction of the frontal lobes can occur following traumatic brain injury (TBI) or other types of acquired brain injury (stroke, aneurysm). These symptoms can include problems with short-term memory, attention, planning, problem solving, impulsivity, disinhibition, poor motivation, and other behavioral and cognitive deficits ("frontal lobe syndrome"). These symptoms may respond to certain drugs, such as dopaminergic agents. This case series describes results of using amantadine in 7 patients with this type of symptom profile (6 with TBI, 1 with meningitis following sinus surgery). Patients received neuropsychiatric examinations and serial neuropsychological testing. All patients showed some degree of positive response. One had side effects that resolved upon discontinuation of drug. The rationale for using dopaminergics is discussed, and pertinent literature is reviewed.</description><identifier>ISSN: 0895-0172</identifier><identifier>EISSN: 1545-7222</identifier><identifier>DOI: 10.1176/jnp.9.2.222</identifier><identifier>PMID: 9144101</identifier><language>eng</language><publisher>United States: American Psychiatric Publishing</publisher><subject>Adult ; Amantadine - administration &amp; dosage ; Amantadine - therapeutic use ; Brain Injuries - complications ; Brain Injuries - physiopathology ; Cognition Disorders - diagnosis ; Cognition Disorders - drug therapy ; Cognition Disorders - etiology ; Dopamine Agents - administration &amp; dosage ; Dopamine Agents - therapeutic use ; Female ; Frontal Lobe - physiopathology ; Humans ; Male ; Middle Aged ; Neuropsychological Tests</subject><ispartof>The journal of neuropsychiatry and clinical neurosciences, 1997, Vol.9 (2), p.222-230</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a317t-56afffb769f4896137628fbe6b182b78b2123b5e5bcf0a0a20d7e45a63223c803</citedby><cites>FETCH-LOGICAL-a317t-56afffb769f4896137628fbe6b182b78b2123b5e5bcf0a0a20d7e45a63223c803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/jnp.9.2.222$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/jnp.9.2.222$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,776,780,2842,2846,4010,21605,21606,21607,21608,27900,27901,27902,77534,77535,77537,77542</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9144101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kraus, M F</creatorcontrib><creatorcontrib>Maki, P M</creatorcontrib><title>Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review</title><title>The journal of neuropsychiatry and clinical neurosciences</title><addtitle>J Neuropsychiatry Clin Neurosci</addtitle><description>Symptoms consistent with dysfunction of the frontal lobes can occur following traumatic brain injury (TBI) or other types of acquired brain injury (stroke, aneurysm). These symptoms can include problems with short-term memory, attention, planning, problem solving, impulsivity, disinhibition, poor motivation, and other behavioral and cognitive deficits ("frontal lobe syndrome"). These symptoms may respond to certain drugs, such as dopaminergic agents. This case series describes results of using amantadine in 7 patients with this type of symptom profile (6 with TBI, 1 with meningitis following sinus surgery). Patients received neuropsychiatric examinations and serial neuropsychological testing. All patients showed some degree of positive response. One had side effects that resolved upon discontinuation of drug. The rationale for using dopaminergics is discussed, and pertinent literature is reviewed.</description><subject>Adult</subject><subject>Amantadine - administration &amp; dosage</subject><subject>Amantadine - therapeutic use</subject><subject>Brain Injuries - complications</subject><subject>Brain Injuries - physiopathology</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - drug therapy</subject><subject>Cognition Disorders - etiology</subject><subject>Dopamine Agents - administration &amp; dosage</subject><subject>Dopamine Agents - therapeutic use</subject><subject>Female</subject><subject>Frontal Lobe - physiopathology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuropsychological Tests</subject><issn>0895-0172</issn><issn>1545-7222</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkM1LwzAYxoMoc05PnoWcRJDOJP1I603G_ICBFz2HpH3DMtqkJq3S_96MDU-e3geeHw-8P4SuKVlSyouHne2X1ZItGWMnaE7zLE94zKdoTsoqTwjl7BxdhLAjhLC0yGZoVtEso4TOUVhrDfWAncayk3aQjbGAt1PjXb1tnTcNYGdxmLp-cF3Yc9q7yLW4dQpwMwU92nowETIWKy_NPuxGPz3iWgbAYRgbAwFL22AP3wZ-LtGZlm2Aq-NdoM_n9cfqNdm8v7ytnjaJTCkfkryQWmvFi0pnZVXQlBes1AoKRUumeKkYZanKIVe1JpJIRhoOWS6LlLG0Lkm6QLeH3d67rxHCIDoTamhbacGNQfCKkDLLeATvD2DtXQgetOi96aSfBCVir1hExaISTEStkb45zo6qg-aPPTqN_d2hl31vxM6N3sYv_536BQZkhis</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>Kraus, M F</creator><creator>Maki, P M</creator><general>American Psychiatric Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1997</creationdate><title>Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review</title><author>Kraus, M F ; Maki, P M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a317t-56afffb769f4896137628fbe6b182b78b2123b5e5bcf0a0a20d7e45a63223c803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adult</topic><topic>Amantadine - administration &amp; dosage</topic><topic>Amantadine - therapeutic use</topic><topic>Brain Injuries - complications</topic><topic>Brain Injuries - physiopathology</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - drug therapy</topic><topic>Cognition Disorders - etiology</topic><topic>Dopamine Agents - administration &amp; dosage</topic><topic>Dopamine Agents - therapeutic use</topic><topic>Female</topic><topic>Frontal Lobe - physiopathology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuropsychological Tests</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kraus, M F</creatorcontrib><creatorcontrib>Maki, P M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of neuropsychiatry and clinical neurosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kraus, M F</au><au>Maki, P M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review</atitle><jtitle>The journal of neuropsychiatry and clinical neurosciences</jtitle><addtitle>J Neuropsychiatry Clin Neurosci</addtitle><date>1997</date><risdate>1997</risdate><volume>9</volume><issue>2</issue><spage>222</spage><epage>230</epage><pages>222-230</pages><issn>0895-0172</issn><eissn>1545-7222</eissn><abstract>Symptoms consistent with dysfunction of the frontal lobes can occur following traumatic brain injury (TBI) or other types of acquired brain injury (stroke, aneurysm). These symptoms can include problems with short-term memory, attention, planning, problem solving, impulsivity, disinhibition, poor motivation, and other behavioral and cognitive deficits ("frontal lobe syndrome"). These symptoms may respond to certain drugs, such as dopaminergic agents. This case series describes results of using amantadine in 7 patients with this type of symptom profile (6 with TBI, 1 with meningitis following sinus surgery). Patients received neuropsychiatric examinations and serial neuropsychological testing. All patients showed some degree of positive response. One had side effects that resolved upon discontinuation of drug. The rationale for using dopaminergics is discussed, and pertinent literature is reviewed.</abstract><cop>United States</cop><pub>American Psychiatric Publishing</pub><pmid>9144101</pmid><doi>10.1176/jnp.9.2.222</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0895-0172
ispartof The journal of neuropsychiatry and clinical neurosciences, 1997, Vol.9 (2), p.222-230
issn 0895-0172
1545-7222
language eng
recordid cdi_proquest_miscellaneous_79008447
source MEDLINE; American Psychiatric Publishing Journals (1997-Present); EZB-FREE-00999 freely available EZB journals; Psychiatry Legacy Collection Online Journals 1844-1996
subjects Adult
Amantadine - administration & dosage
Amantadine - therapeutic use
Brain Injuries - complications
Brain Injuries - physiopathology
Cognition Disorders - diagnosis
Cognition Disorders - drug therapy
Cognition Disorders - etiology
Dopamine Agents - administration & dosage
Dopamine Agents - therapeutic use
Female
Frontal Lobe - physiopathology
Humans
Male
Middle Aged
Neuropsychological Tests
title Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T13%3A33%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20amantadine%20hydrochloride%20on%20symptoms%20of%20frontal%20lobe%20dysfunction%20in%20brain%20injury:%20case%20studies%20and%20review&rft.jtitle=The%20journal%20of%20neuropsychiatry%20and%20clinical%20neurosciences&rft.au=Kraus,%20M%20F&rft.date=1997&rft.volume=9&rft.issue=2&rft.spage=222&rft.epage=230&rft.pages=222-230&rft.issn=0895-0172&rft.eissn=1545-7222&rft_id=info:doi/10.1176/jnp.9.2.222&rft_dat=%3Cproquest_cross%3E79008447%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79008447&rft_id=info:pmid/9144101&rfr_iscdi=true